Cholinergic degeneration and early cognitive signs in prodromal Lewy body dementia
Alzheimer's & Dementia · 2025
DOI: 10.1002/alz.14584 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von Kyung Ah Woo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul National University College of Medicin…. Hauptthemen laut MEDLINE: Lewy Body Disease, Basal Forebrain, REM Sleep Behavior Disorder. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Science and ICT, South Korea, Ministry of Education.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION Isolated REM sleep behavior disorder (iRBD) is a strong prodromal marker of Lewy body diseases (LBDs) – Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Cholinergic loss is linked to cognitive decline in these conditions, but its trajectory remains unclear. METHODS In a cohort of 92 iRBD participants with baseline MRI, cholinergic basal forebrain (cBF) volume was measured, with longitudinal changes analyzed in 49 with follow‐up scans. Cross‐sectional neuropsychological associations were examined across a broader RBD–LBD continuum, including the iRBD cohort plus 65 PD and 15 DLB patients with probable RBD. RESULTS cBF volume declined at comparable rates in iRBD‐to‐PD and iRBD‐to‐DLB converters, but atrophy was more severe at DLB phenoconversion. cBF atrophy correlated with attention, executive, and memory deficits. In iRBD, baseline cBF z ‐score < −1.0 predicted dementia (hazard ratio = 9.57, p = .009). CONCLUSION cBF degeneration evolves from the prodromal iRBD stage of LBDs and predicts dementia, highlighting a window for cholinergic‐targeted intervention. Highlights Basal forebrain links to attention, executive function, and memory in the RBD continuum. Basal forebrain atrophy progresses at similar rates in prodromal PD and prodromal DLB. At phenoconversion, basal forebrain atrophy is greater in DLB than in PD converters. Basal forebrain atrophy strongly predicts future dementia in iRBD. Executive dysfunction predicts faster basal forebrain degeneration in iRBD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul National University College of Medicine, Dongjak-gu, Seoul, Republic of Korea.
- Department of Nuclear Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul National University College of Medicine, Dongjak-gu, Seoul, Republic of Korea.
- Institute of Radiation Medicine, Medical Research Center, Seoul National University, Seoul, Republic of Korea.
- Department of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
ORCID-Profile: Kyung Ah Woo, Jee-Young Lee
Förderung
- National Research Foundation of Korea
- Ministry of Science and ICT, South Korea
- Ministry of Education
Zitieren
APA
Woo, K. A., Kim, H., Kim, R., Jin, B., Shin, J. H., Kim, S., Kim, Y. K., Nam, H., Jeon, B., & Lee, J. Y. (2025). Cholinergic degeneration and early cognitive signs in prodromal Lewy body dementia. Alzheimer's & Dementia. https://doi.org/10.1002/alz.14584
Vancouver
Woo KA, Kim H, Kim R, Jin B, Shin JH, Kim S, et al. Cholinergic degeneration and early cognitive signs in prodromal Lewy body dementia. Alzheimer's & Dementia. 2025. doi:10.1002/alz.14584
BibTeX
@article{Woo2025,
author = {Woo, Kyung Ah and Kim, Heejung and Kim, Ryul and Jin, Bora and Shin, Jung Hwan and Kim, Seoyeon and Kim, Yu Kyeong and Nam, Hyunwoo and Jeon, Beomseok and Lee, Jee-Young},
title = {Cholinergic degeneration and early cognitive signs in prodromal Lewy body dementia},
journal = {Alzheimer's & Dementia},
year = {2025},
doi = {10.1002/alz.14584}
}
EUVIMED